毕得医药 - Financials

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	1.1B	1.1B	834.0M	606.0M	391.0M
Revenue Growth %	0.9%	30.9%	37.6%	55.0%	--
Total Revenue	1.1B	1.1B	834.0M	606.0M	391.0M
Cost Of Revenue	647.0M	655.0M	464.0M	306.0M	179.0M
+Gross Profit	455.0M	437.0M	370.0M	300.0M	212.0M
Gross Margin %	41.3%	40.0%	44.4%	49.5%	54.2%
Total Operating Cost	970.0M	964.0M	673.0M	504.0M	326.0M
Selling Expenses	127.0M	127.0M	92.7M	78.4M	50.7M
Admin Expenses	115.0M	120.0M	71.9M	64.0M	51.6M
Rd Expenses	59.1M	63.2M	46.1M	34.9M	21.5M
Finance Expenses	-21.8M	-29.6M	-17.9M	5.0M	9.6M
+Operating Income	148.0M	127.0M	172.0M	115.0M	70.8M
Operating Margin %	13.4%	11.6%	20.6%	19.0%	18.1%
Non Operating Income	725,300	59,800	40,300	350,700	80,700
Non Operating Expenses	1.0M	692,200	1,800	436,800	632,000
Investment Income	1.6M	3.8M	59,600	408,100	500,600
Fair Value Change Income	3.1M	-12.6M	-463,900	--	--
Asset Disposal Income	856,300	438,700	--	7.9M	93,700
Asset Impairment Loss	33.8M	18.3M	7.5M	9.5M	8.7M
Other Income	10.3M	7.0M	10.8M	4.1M	4.5M
Income Before Tax	148.0M	126.0M	172.0M	115.0M	70.3M
Income Tax	30.6M	17.6M	25.8M	17.0M	11.3M
+Net Income	117.0M	108.0M	146.0M	97.6M	59.0M
Net Margin %	10.6%	9.9%	17.5%	16.1%	15.1%
Net Income Attributable	117.0M	110.0M	146.0M	97.6M	59.0M
Minority Interest	--	-1.1M	--	--	--
Eps Basic	1.32	1.21	1.98	2.04	1.33
Eps Diluted	1.32	1.21	2.77	2.04	1.33

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.1B	1.3B	1.5B	193.0M	91.4M
Trading Financial Assets	75.5M	122,500	4.0M	--	43.0M
Accounts Receivable	223.0M	235.0M	177.0M	125.0M	84.9M
Notes Receivable	4.4M	2.3M	339,400	--	--
Notes And Accounts Receivable	227.0M	237.0M	177.0M	125.0M	84.9M
Prepayments	6.2M	9.2M	6.7M	3.5M	2.7M
Inventory	760.0M	699.0M	522.0M	477.0M	219.0M
Total Current Assets	2.2B	2.3B	2.2B	818.0M	458.0M
Fixed Assets	--	42.8M	39.1M	31.1M	15.3M
Fixed Assets Total	101.0M	42.8M	39.1M	31.1M	15.3M
Construction In Progress	--	--	5.1M	--	--
Construction In Progress Total	15.4M	--	5.1M	--	--
Intangible Assets	3.9M	600,700	211,800	442,700	675,800
Long Term Deferred Expenses	23.7M	37.6M	16.8M	22.1M	22.6M
Total Non Current Assets	209.0M	154.0M	115.0M	88.4M	50.1M
Total Assets	2.4B	2.4B	2.4B	906.0M	508.0M
Short Term Borrowings	30.2M	231,200	9.6M	72,000	17.1M
Accounts Payable	216.0M	180.0M	167.0M	206.0M	83.2M
Advance Receipts	--	--	--	--	--
Contract Liabilities	36.7M	29.1M	20.5M	14.7M	10.6M
Total Current Liabilities	346.0M	275.0M	249.0M	250.0M	143.0M
Total Non Current Liabilities	45.2M	50.5M	34.0M	27.7M	--
Total Liabilities	391.0M	325.0M	283.0M	277.0M	143.0M
Paid In Capital	90.9M	90.9M	64.9M	48.7M	45.0M
Capital Reserve	1.8B	1.8B	1.8B	483.0M	321.0M
Surplus Reserve	29.7M	27.5M	19.0M	9.6M	2.8M
Retained Earnings	260.0M	225.0M	223.0M	86.9M	-3.8M
Equity Attributable	2.0B	2.1B	2.1B	629.0M	364.0M
Total Equity	2.0B	2.1B	2.1B	629.0M	364.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	1.2B	1.1B	872.0M	609.0M	400.0M
Tax Refunds Received	51.2M	62.2M	36.7M	29.3M	13.2M
Total Operating Cash Inflow	1.3B	1.2B	923.0M	647.0M	419.0M
Cash Paid For Goods	796.0M	953.0M	661.0M	519.0M	275.0M
Cash Paid To Employees	183.0M	183.0M	125.0M	98.0M	68.2M
Taxes Paid	71.0M	64.7M	62.2M	42.0M	27.5M
Total Operating Cash Outflow	1.1B	1.3B	894.0M	712.0M	415.0M
Operating Cash Flow	158.0M	-57.4M	29.9M	-64.9M	3.6M
Total Investing Cash Inflow	694.0M	78.0M	108.0M	58.6M	82.8M
Total Investing Cash Outflow	853.0M	107.0M	151.0M	29.2M	163.0M
Investing Cash Flow	-158.0M	-28.9M	-42.6M	29.4M	-79.9M
Cash From Borrowings	97.3M	231,200	9.6M	20.7M	33.6M
Dividends And Interest Paid	79.9M	100.0M	83,600	188,000	23.9M
Debt Repayments	68.0M	9.5M	72,000	37.7M	41.7M
Total Financing Cash Inflow	105.0M	5.2M	1.3B	185.0M	194.0M
Total Financing Cash Outflow	272.0M	144.0M	34.5M	47.2M	66.6M
Financing Cash Flow	-167.0M	-138.0M	1.3B	137.0M	127.0M
Net Change In Cash	-168.0M	-230.0M	1.3B	102.0M	47.4M
Ending Cash Balance	1.1B	1.3B	1.5B	193.0M	91.4M
Capex	88.3M	61.1M	38.4M	29.2M	37.7M